Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    "Selective IgA deficiency"
Show Display Options
Rank Status Study
1 Completed B-Lymphocyte Stimulator (BLyS) To Treat Selective IgA Deficiency
Condition: IgA Deficiency
Intervention: Drug: B-Lymphocyte Stimulator (BLyS)

Indicates status has not been verified in more than two years